Delivery Order SPE2DE21D7020-SPE2D625F1DJR
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $2,931.60 by the Defense Health Agency's Medical Supply Chain for a selective MC single straight 155cm medical device. The contract, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp has been awarded a delivery order valued at $41,218.20 by the Defense Health Agency's Medical Supply Chain for the provision of medical devices and supplies. The contract, awarded on July 28, 2025, utilizes a fixed-price structure with economic price adjustment provisions and is set to reach completion by July 31, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a non-set-aside competitive procurement,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp was awarded a delivery order valued at $8,446.40 by the Defense Health Agency's Medical Supply Chain on September 4, 2024, with an ultimate completion date of September 11, 2024. The contract, designated as fixed-price with economic price adjustment, involves the delivery of medical devices or supplies to support defense healthcare operations. The performance location is Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was awarded without a...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,402.62 by the Defense Health Agency's Medical Supply Chain for AMPLATZ SS 75cm .035 medical devices (5-pack units). This fixed-price delivery order with economic price adjustment was awarded on July 24, 2025, with an ultimate completion date of July 31, 2025. The contract carries no set-aside designation, indicating open competition in the federal marketplace. The place of...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp has been awarded a delivery order valued at $12,397.96 for medical supplies under the Defense Health Agency's Medical Supply Chain program. The contract, designated as a fixed-price agreement with economic price adjustment provisions, was awarded on July 28, 2025, with an ultimate completion date of August 4, 2025. The work will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. This delivery order was not set aside for any...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1DJRDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $7,968.47 for a selective MC single straight 130cm medical device component, with a contract completion date of August 22, 2025. The award, issued on August 15, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's headquarters in Marlborough, MA, and is funded through the Defense Health Agency's Medical Supply Chain, which supports medical device procurement across the Department of Defense healthcare system. This delivery order represents a discrete purchase under Boston Scientific's broader relationship with the Defense Health Agency, consistent with the company's established role as a premier supplier of advanced medical technologies to federal healthcare agencies. Boston Scientific maintains multiple indefinite delivery vehicles with the DHA and Veterans Integrated Service Networks, positioning the company as a critical supplier of specialized medical devices including cardiovascular interventions, neurostimulation systems, stents, and diagnostic equipment. The modest individual order value reflects the typical structure of task orders issued against such blanket purchase agreements, enabling the DHA to procure specialized medical components on an as-needed basis to support federal healthcare delivery requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/15/25 |